A study to investigate the effect of capivasertib on the pharmacokinetics of oral rosuvastatin in healthy participants

Trial Identifier:	D3615C00006
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	July 2025
Primary Completion Date:	September 2025
Study Completion Date:	September 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, MD	Baltimore, MD, US, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.